2024;30:e70016
Notably, a post-injury course that is not reversed always presents a devastating progression
The FDA also noted that reporting systems have limitations and that adverse events linked to compounded products may not always be reported
All products sold by Bluebonnet Peptides are strictly for research use only and are not intended for human or animal consumption, medical, or therapeutic use
Vice versa, direct occlusion of the superior mesenteric vessels, vein, artery, or vein and artery (i.e., portal, caval hypertension, aortal hypotension, peripheral lesions) rapidly induced the intracranial (superior sagittal sinus) hypertension, brain swelling, and lesions [14,15,16]
The potential for peptides to one day become approved treatments for a host of debilitating injuries and conditions is immense